Journal - Current Drug Targets

Impact Factor

Current: 3
5 - Year: 3.3

Ranking & Category

131st of 267 in Pharmacology & Pharmacy

Topic(s) Covered

2 Topic(s)

View

Aims & Scope

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.

Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication full-length/mini review articles and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Abstracted & Indexed in:

Biological Abstracts BIOSIS Previews British Library Cabell's Directory/Journalytics Cambridge Scientific Abstracts (CSA)/ProQuest CNKI Scholar EBSCO EMBASE EMBiology ERA 2018 Essential Science Indicators Genamics Journal Seek Google Scholar Index Copernicus Index Medicus J-Gate Journal Citation Reports/Science Edition JournalTOCs MediaFinder®-Standard Periodical Directory MEDLINE/PubMed Norwegian Register OpenAire PubsHub QOAM Science Citation Index Expanded™ (SciSearch®) ScienceGate Scilit Scopus Suweco CZ Ulrich's Periodicals Directory

Archiving and Copyright:

Portico Sherpa Romeo

Journal Database:

Dimensions

COPE Compliant

Archived in

Endorsement(s)

"In view of the growing volume of literature, the role of high quality review journals has become increasingly important. Current Drug Targets is an important journal in the field of medicinal chemistry and drug design, which is strongly recommended to the scientific community."

Jean-Marie Lehn
Nobel Laureate